Shares of Eden Research plc (LON:EDEN – Get Free Report) traded down 13.2% on Monday . The stock traded as low as GBX 2.26 ($0.03) and last traded at GBX 2.37 ($0.03). 1,775,147 shares changed hands during trading, an increase of 133% from the average session volume of 762,776 shares. The stock had previously closed at GBX 2.73 ($0.04).
Eden Research Stock Performance
The stock has a market cap of £14.35 million, a PE ratio of -9.42 and a beta of 0.92. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42. The firm has a 50 day moving average of GBX 3.36 and a two-hundred day moving average of GBX 3.71.
Insider Transactions at Eden Research
In other news, insider Alexander John Abrey acquired 167,947 shares of Eden Research stock in a transaction on Tuesday, March 4th. The stock was bought at an average price of GBX 3 ($0.04) per share, for a total transaction of £5,038.41 ($6,513.78). Also, insider Lykele van der Broek bought 256,000 shares of the stock in a transaction dated Thursday, February 6th. The shares were acquired at an average price of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($13,238.53). In the last quarter, insiders purchased 1,391,473 shares of company stock worth $103,604,725. 14.02% of the stock is currently owned by insiders.
Eden Research Company Profile
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
See Also
- Five stocks we like better than Eden Research
- Stock Sentiment Analysis: How it Works
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- How to Plot Fibonacci Price Inflection Levels
- The 3 Most Talked About Investments on WallStreetBets Right Now
- How to Capture the Benefits of Dividend Increases
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.
